Seattle, WA, United States of America

Daniel Ellis

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Seattle, WA (US) (2017 - 2023)
  • Tempe, AZ (US) (2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
7 patents (USPTO):

Title: The Innovative Contributions of Daniel Ellis

Introduction

Daniel Ellis is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of vaccine development. With a total of seven patents to his name, Ellis has focused on creating innovative solutions to combat viral infections, particularly influenza and coronaviruses. His work has the potential to impact public health positively.

Latest Patents

Among his latest patents is a groundbreaking development in nanoparticle-based influenza virus vaccines. This invention involves nanoparticles made from self-assembling proteins that are designed to elicit an immune response against hemagglutinin (HA) proteins from a broad range of influenza viruses. The immunogenic portion of the influenza HA protein is displayed on the nanoparticle surface, making these nanoparticles useful for vaccinating subjects against the influenza virus.

Another notable patent involves stable coronavirus proteins and vaccine compositions. This invention provides compositions and methods that include mutated coronavirus 'S' spike proteins or receptor binding domains with increased expression levels, yield, and stability compared to their native counterparts. These mutated spike proteins can be utilized to generate a protein-based vaccine against one or more coronaviruses, showcasing Ellis's commitment to addressing emerging viral threats.

Career Highlights

Daniel Ellis has had a distinguished career, working with esteemed institutions such as the University of Washington and Fred Hutchinson Cancer Center. His research has been pivotal in advancing the understanding and treatment of viral infections, particularly in the context of vaccine development.

Collaborations

Throughout his career, Ellis has collaborated with notable scientists, including Neil P. King and David Baker. These collaborations have enriched his research and contributed to the success of his innovative projects.

Conclusion

Daniel Ellis's work exemplifies the spirit of innovation in the field of vaccine development. His patents reflect a deep commitment to improving public health through scientific advancements. The impact of his inventions will likely be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…